News

New Atlas8h
Dual-target weight-loss drug is 47% more effective than its rival
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
TCTMD16h
Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Applied Clinical Trials Online21h
Tirzepatide Demonstrates Superior Weight Loss to Semaglutide in 72-Week Phase IIIb SURMOUNT-5 Trial
In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...
Which Weight-Loss Drug Works the Best?
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
You can be prescribed them both for weight loss, but one of them seems to work better
The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...
Weight-loss jab Mounjaro helps people shed much more weight than rival – study
Weight-loss jab Mounjaro helps people shed much more weight than rival – study - Mounjaro (tirzepatide) and Wegovy ...
Weight loss injections may have powerful anti-cancer effect, research suggests
Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...